Emotional eaters less likely to lose weight on Ozempic, study suggests
The one surprising impact of weight loss jab Ozempic
Japanese researchers suggest that Ozempic and similar weight loss drugs may be less effective for individuals who engage in emotional eating.
Dr. Takehiro Kato theorizes that psychological factors influencing emotional eating are not directly addressed by GLP-1 receptor agonist therapy, potentially requiring additional support.
The study found that while initial eating restraint improved, emotional eating tendencies often reappeared after approximately one year of taking the drug.
Individuals who overate in response to appealing food, rather than emotional triggers, were more likely to achieve and maintain long-term weight loss with the medication.
These preliminary findings, based on a study of 92 Japanese patients with type 2 diabetes, have implications for millions of Americans using weight loss drugs, with obesity often linked to emotional eating.